APA (7th ed.) Citation

GS, D., I, B., İ, A., T, B., R, G., CF, B., . . . M, C. (2026). Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study. Infectious diseases and therapy, 15(3), 769. https://doi.org/10.1007/s40121-025-01298-w

Chicago Style (17th ed.) Citation

GS, Dbaibo, et al. "Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study." Infectious Diseases and Therapy 15, no. 3 (2026): 769. https://doi.org/10.1007/s40121-025-01298-w.

MLA (9th ed.) Citation

GS, Dbaibo, et al. "Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study." Infectious Diseases and Therapy, vol. 15, no. 3, 2026, p. 769, https://doi.org/10.1007/s40121-025-01298-w.